Plant Health Care PLC
24 September 2007
Embargoed until 7.00 24 September 2007
PLANT HEALTH CARE PLC
('Plant Health Care' or 'the Company')
Myconate Field Trial Update
- Significant yield improvement demonstrated on a variety of crops -
Plant Health Care (AIM: PHC.L), a leading provider of natural products for
plants and soil, is pleased to report the success of recent Myconate tests. The
trials, which were all undertaken in the US, are part of the extensive
development programme underway and further reinforce the commercial potential of
Myconate.
When applied to carrots in furrow application at seeding, Myconate produced a
resultant yield improvement in excess of 30% in two separate trials. Both trials
were carried out independently by a major Wisconsin vegetable grower.
Celery trials in Wisconsin demonstrated a 14% harvestable yield increase when
Myconate was applied as a pre-plant, transplant spray. Against the control,
tests showed a 12% increase in total weight and 12% increase in top weight. A
13% yield increase was achieved in trials on onions and, as with celery,
application was by pre-plant, transplant spray. Additionally, a 13% increase in
bulb weight and 11% increase in diameter were recorded.
The results of Myconate trials on grain and straw in winter wheat, tested using
a variety of applications and produced particularly pleasing yield improvements.
When applied as a seed treatment yield increased as much as 5.4% and when
applied as a ground spray the improvement was up to 7.4%. Additionally,
Myconate's application as both a seed treatment and a ground spray delivered
yield increases of up to 9.4%.
Commenting on the trials, John Brady, Chief Executive of Plant Health Care,
said:
'The increase in yields on grain and straw in severe winter conditions are very
pleasing and the results of these tests are compelling, confirming Myconate's
efficacy through a number of applications. The results achieved highlight the
opportunity Myconate presents on a broad range of crops and vegetables. We are
committed to delivering shareholder value through the commercialisation of our
natural technologies and the ongoing development and marketing of Myconate and
Harpin is central to our strategy.'
-Ends-
For further information please contact:
John Brady, Chief Executive
Plant Heath Care plc
26-28 September Tel: 020 7920 3150
Therafter: 001 603 525 3702
Tavistock Communications
Jeremy Carey/Matt Ridsdale
Tel: 020 7920 3150
Evolution Securities Limited
Tim Worlledge/Tim Redfern
Tel: 020 7071 4300
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.